We suspect that the complete absence of Tsc2 in these Tsc2+/− cystadenoma lesions leads to strong activation of mTORC1 due to constitutive high levels of RHEB-GTP, which makes these lesions resistant to the lesser effect of Raptor phosphorylation. Here, RPTOR is linked to cystadenoma.